This was the stock's fifth consecutive day of losses.

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor ...

Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...

BECTON, DICKINSON Hedge Fund Activity We have seen 686 institutional investors add shares of BECTON, DICKINSON stock to their portfolio, and 754 decrease their positions in their most recent quarter.

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...

Investors in Becton, Dickinson & Co (Symbol: BDX) saw new options begin trading today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $3.35 EPS for the quarter, beating ...

Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...

On January 14, 2025, Becton, Dickinson and Company (NYSE:BDX) stock closed at $235.80 per share with a market capitalization of $68.38 billion.

Becton, Dickinson and Company (NYSE: BDX) has near-perfection dividend credibility and has been a very solid dividend payer since 1962.